LEKAPHARM A/S: Financial statements 2013
CVR: 32945945
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
LEKAPHARM A/S (CVR 32945945) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,482,090 and a net result of DKK 1,047,864. Equity in the 2013 report amounted to DKK 11,784,228. The solvency ratio was 83%.
- Gross Profit
- DKK 4,482,090
- Profit/Loss
- DKK 1,047,864
- Equity
- DKK 11,784,228
- Total Assets
- DKK 14,196,564
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of October 1, 2013, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of LEKAPHARM A/S.
As of October 1, 2013, ND REVISION ODENSE REGISTRERET REVISIONSAKTIESELSKAB has stepped down as auditor of LEKAPHARM A/S.
LEKAPHARM A/S has published its annual report for 2012.
About LEKAPHARM A/S
LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The board consists of Susanne Frederiksen (chair), Emil Bødker Kjeldsen and Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.